UPCLIXOR Trademark

Trademark Overview


On Friday, September 26, 2025, a trademark application was filed for UPCLIXOR with the United States Patent and Trademark Office. The USPTO has given the UPCLIXOR trademark a serial number of 99414733. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 17, 2026. This trademark is owned by Bristol-Myers Squibb Company. The UPCLIXOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
upclixor

General Information


Serial Number99414733
Word MarkUPCLIXOR
Filing DateFriday, September 26, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2026

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
US

Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
US

Trademark Events


Event DateEvent Description
Friday, September 26, 2025NEW APPLICATION ENTERED
Friday, September 26, 2025APPLICATION FILING RECEIPT MAILED
Monday, February 16, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 18, 2026ASSIGNED TO EXAMINER
Friday, February 20, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 17, 2026PUBLISHED FOR OPPOSITION
Tuesday, March 17, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED